Dr. Shalini Srivastava – The Associate Director Clinical Development at Vedic Lifesciences – has more than 20 years of experience in clinical research. She is a Post Graduate from the University of Cranfield, UK and a Certificate in Project Management from University of Adelaide, Australia. Some of her most prestigious associations have been her work on an orphan drug for Muklewell Syndrome and her stupendous work on Rotavirus vaccine. She is one of the US patent holders for a product called EnXtra. Her past experience includes Director of a Pharma CRO. She is the brain behind the clinical operations and is a striving, motivating and deciding force of all the projects and their leads at Vedic.